Please note: AABB reserves the right to make updates to this program.
Live Program Date: Thursday, June 22, 2023 - On-Demand Available
Presented by Terumo Blood and Cell Technologies
Currently more than 94% of the platelet supply in the United States is collected by apheresis1. With the decline in the apheresis donor population and continued post-COVID blood supply challenges, whole blood derived platelets can be a boost to the platelet supply. US blood collectors should reconsider the option of whole blood derived platelets2.
Join us to hear leaders in the industry, representing both blood centers and hospitals, share their perspectives on the merits of whole blood derived platelets.
1Jones et al. Has the trend of declining blood transfusions in the United States ended? Findings of the 2019 National Blood Collection and Utilization Survey. Transfusion. 2021;61:S1–S10
2Stubbs et al. The current state of the platelet supply in the US and proposed options to decrease the risk of critical shortages. Transfusion. 2021;61:303-312J
This on-demand Science & Innovation Forum is complimentary to all, but registration is required. By registering for this AABB-hosted program you consent to have your information shared with the program sponsor, Terumo Blood and Cell Technologies. Register here.
Moderator: Anna Razatos, PhD
Global Scientific Marketing
Terumo Blood and Cell Technologies
Speaker: Gustaaf de Ridder, MD
Transfusion Medicine Director
Geisinger Medical Center
Speaker: Mark H. Yazer, MD
Professor of Pathology
University of Pittsburgh
The content of this event was developed independently from the AABB continuing education program. The opinions expressed are those of the faculty. Continuing education credit is not offered.
Science & Innovation Forums are live and on-demand programs that are presented by companies serving the AABB community and target critical needs in the field that can be addressed by the sponsor’s solutions technology. Registration is complimentary to all.